Pharmaceutical Company Structure Analysis 2010 to 2011

Language:
Japanese
Product Code No:
C53109200
Issued In:
2011/06
#of Pages:
291
Publication Cycle:
Other
Format:
PDF

Price

110,000 yen ($1,022.30)
(excluding consumption tax)
220,000 yen ($2,044.61)
(excluding consumption tax)
330,000 yen ($3,066.91)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 107.6 yen , 2020/04/01 Japan)

Coverage: (Product/service)

Pharmaceutical company structure

Research Target:

Pharmaceutical companies

Research Content:

 

I. Company Trends
Japanese companies and foreign capital companies, number of companies by employee size, number of companies by capital size, number of companies by establishment generation, banks, number of medical representatives, R&D division size, production division size, company sales, profit and profitability, pharmaceutical sales, ethical drugs and OTC drugs, R&D cost, listing on NHI price list, overseas sales (consolidated), trading firms, pharmaceutical wholesalers, etc.
 
II. Overseas Presence
Trends of overseas bases, overseas presence by region, list of companies that have advanced to overseas markets
 
III. Developments of New Drugs by Pharmacologic Effect
Central nervous system agents, peripheral nervous system agents, sensory organ agents, allergy and asthma agents, cardiovascular agents, gastrointestinal agents, hormone agents, genitourinary agents, epidermal agents, vitalizers & tonics, blood and body fluid agents, metabolism agents, antineoplastics, antibiotics, chemotherapeutics, biological preparations, testing reagents

Price

written in Japanese
110,000 yen ($1,022.30)
(excluding consumption tax)
220,000 yen ($2,044.61)
(excluding consumption tax)
330,000 yen ($3,066.91)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 107.6 yen , 2020/04/01 Japan)